Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
about
Nitric oxide and pH modulation in gynaecological cancerRedox regulation of ischemic limb neovascularization - What we have learned from animal studiesThe NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.The Daniel K. Inouye College of Pharmacy Scripts: Poha Berry (Physalis peruviana) with Potential Anti-inflammatory and Cancer Prevention ActivitiesAntitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cellsRhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathwaysDo signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study.Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.Lentinan protects pancreatic β cells from STZ-induced damage.Gasotransmitters in cancer: from pathophysiology to experimental therapy.Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer.Role of RPL39 in Metaplastic Breast Cancer.Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.The EMT spectrum and therapeutic opportunities.Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review)Significance of twist and iNOS expression in human breast carcinoma.Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid LeukemiaExpression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer.Cytoglobin Promotes Cardiac Progenitor Cell Survival against Oxidative Stress via the Upregulation of the NFκB/iNOS Signal Pathway and Nitric Oxide Production.Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.Targeting iNOS to increase efficacy of immunotherapies.Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways.Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.NO and COX2: Dual targeting for aggressive cancers.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis.Glioma and microglia, a double entendre.Total Flavonoids from Radix Glycyrrhiza Exert Anti-Inflammatory and Antitumorigenic Effects by Inactivating iNOS Signaling Pathways.Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsPolycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing miceiNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
P2860
Q26741063-F6859CAD-1190-426C-B45E-25A1E7B16356Q33681553-ED3E066F-182F-4BE5-8345-A070B3E1F68BQ35819880-C0842931-BCE0-4EA4-A8B5-FD7BCB13FA97Q36035570-EC46E4B3-2598-45B6-8E79-F8F84313A6DBQ36090325-5F51E713-6EB0-465C-95B9-CCA9AD507CCAQ36213996-729D01B5-BFA9-452A-B82C-8486F384A268Q36457669-65EE77A2-54A2-442D-8E10-09F8CBC6CBA0Q36592001-B422B83D-3B62-4AF8-B3EC-80C6F73F2472Q36955641-5289A095-178E-4D05-AD87-F572E439BE15Q37014210-8367B0F4-442B-478A-952E-3505A54BD39AQ37251605-7A10B6E2-8BCE-4B06-B54E-0BE1618E3A3AQ37656625-5F4F41E4-FB31-4690-AA99-E492BB4A5480Q37718207-C5EDA9A7-12BE-410E-9B3B-2E1F7029CD49Q37720884-447B8F1A-7EC6-4AC1-835C-2F7DA611A65AQ38723382-21945DCD-FD82-408B-A805-1DF0DAADEC55Q38837269-EF5B602B-42AD-46BD-8546-04DC00B4BCCDQ38953498-E7828226-56E2-4083-8CD5-0BE558ED850CQ39329818-A9DBA393-AA2F-402C-8BFE-D119FF2C7017Q39382387-B1FD0D57-0FFA-4C3E-AD97-C03B8D66589EQ40294423-CD7BF088-6E80-4FBF-BA6F-8A0280939AA2Q41089780-B419F548-C246-4052-88AD-04FB28CF6C2BQ41225554-1AF86905-CB1B-4F98-B1DA-E2FC86B385CFQ41540397-32012F88-1A62-4200-ABF3-D0FCDF5365EDQ41670315-F61357E3-E79A-4574-AB91-9CE251AAC575Q42630303-A33E8FA9-CBBF-486C-A739-D14C9C02252CQ43024830-3E6A5B82-6118-4CDF-B215-FF49CB5CB7D6Q45067339-BD799B8B-CC64-4903-9915-B170ADA02103Q45412843-BC2EF868-EF14-4021-A2D9-A090037BD0BDQ47105736-0C747AEC-B8F5-4CB2-8D82-D4FC75CDA391Q47315412-281C2A09-0B18-44DF-B9F7-53573D62E22BQ47711103-DD3BF97A-DB38-4D78-A12B-C937F8EC394AQ48122606-E89D123B-F79C-4FB5-ACC7-32C515FC15F4Q49346285-3209781C-274D-4352-B37F-ECE6BD67C31CQ49544289-605C8BE5-8330-4FFA-9404-679D369DA991Q52362244-2647CB3C-FDE0-431C-8A37-3BC086CDB392Q53824336-04ACC671-E3DE-43DA-962B-1B8D8A0BDC8FQ55333957-48568883-6190-42F1-95E9-5212EB03EC7BQ56889140-29B9901B-1673-442E-94DF-3EE812945348Q57079914-070325C2-0C7C-45A0-ADBE-B238FA2053BEQ57295964-9D2D3259-1483-4165-8DB6-82AD0F6780AD
P2860
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@ast
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@en
type
label
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@ast
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@en
prefLabel
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@ast
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@en
P2093
P2860
P50
P1476
Inhibition of iNOS as a novel ...... triple-negative breast cancer.
@en
P2093
Bhuvanesh Dave
Dong Soon Choi
Elvin Blanco
Heidi L Weiss
Joseph Cusimano
Maria L Guevara
Melissa D Landis
Steven S Gross
Tejal Patel
P2860
P2888
P356
10.1186/S13058-015-0527-X
P577
2015-02-22T00:00:00Z
P5875
P6179
1033791105